Icosapent Ethyl

Overview

Icosapent Ethyl is an ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid that is used to lower triglyceride levels in adults with severe hypertriglyceridemia. It is a prescription medication that has been shown to reduce the risk of cardiovascular events.

API suppliers (2)

Suppliers of Icosapent Ethyl backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Sichuan Baili Pharmaceutical Co., Ltd.China2 active DMF
• SKUNY BIOSCIENCE CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (20 approved US products), the latest listed US patent on Icosapent Ethyl expires 27 Jun 2033. Generic API sourcing typically opens up once these lapse.

Therapeutic areas